+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Virus Filtration Products - Global Market Trajectory & Analytics

  • ID: 4806188
  • Report
  • February 2022
  • Region: Global
  • 475 Pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Abbott Laboratories
  • BioMérieux SA
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Lonza Group AG
  • Pall Corporation

Global Virus Filtration Products Market to Reach US$6.6 Billion by the Year 2026


Virus filtration is a non-destructive, easy, and effective method of maintaining non-enveloped and enveloped virus particles within or on the surface of polymeric membrane pores. Growth in the global market is set to be driven by extensive demand from biotechnology and biopharmaceutical industries. These industries make extensive usage of virus filtration products for protecting their products from any kind of contamination. Other growth boosting factors include favorable regulations, better funding, as well as support to various R&D projects by both private enterprises and government. Increasing investment and focus on research has boosted development of innovative technologies that facilitate manufacturing of novel filtration products capable of filtering minute structures ranging from microorganisms like viruses and bacteria to particles. Growing usage of biotherapeutics has boosted R&D as well as formulation of novel drugs extracted from different natural sources for treatment of an array of chronic disorders. The rising incidence of various diseases and chronic conditions around the world, combined with stringent regulations regarding virus-free therapeutics is likely to propel the virus-filtration industry over the medium-term. Focus on development of high-tech products, supportive government regulations, and launch of novel products is expected to benefit market growth.

Amid the COVID-19 crisis, the global market for Virus Filtration Products estimated at US$3.1 Billion in the year 2020, is projected to reach a revised size of US$6.6 Billion by 2026, growing at a CAGR of 13.1% over the analysis period. Kits & Reagents, one of the segments analyzed in the report, is projected to grow at a 14.7% CAGR to reach US$4.9 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Filtration Systems segment is readjusted to a revised 11% CAGR for the next 7-year period. This segment currently accounts for a 23.9% share of the global Virus Filtration Products market.



The U.S. Market is Estimated at $1.1 Billion in 2021, While China is Forecast to Reach $899.5 Million by 2026


The Virus Filtration Products market in the U.S. is estimated at US$1.1 Billion in the year 2021. The country currently accounts for a 31.98% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$899.5 Million in the year 2026 trailing a CAGR of 16.8% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.7% and 11.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR while Rest of European market (as defined in the study) will reach US$322.9 Million by the end of the analysis period. The virus filtration market is dominated by North America owing to growth in industrialization, patient awareness, presence of modern infrastructure, as well as high per capita expenditure on healthcare. The European market benefits from favorable policies by the government with respect to healthcare infrastructure. Growth in Asia-Pacific region is due to increased demand for high-quality therapeutics in large countries such as China and India. In developing countries like China and India, robust economic growth is supporting biotechnology and pharmaceutical units.

Filtration Systems Segment to Reach $1.4 Billion by 2026


A considerable portion of the growth for virus filtration comes from the biopharmaceutical sector. Amidst the rise in single use filtration products and stringent quality standards, the biopharmaceutical sector is expected to expand the market for membrane technology in the near future. In the global Filtration Systems segment, USA, Canada, Japan, China and Europe will drive the 10.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$570.8 Million in the year 2020 will reach a projected size of US$1.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$150.6 Million by the year 2026, while Latin America will expand at a 11.9% CAGR through the analysis period.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories
  • Asahi Kasei Medical Co., Ltd.
  • BioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Lonza Group AG
  • Pall Corporation
  • QIAGEN
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • WuXi Biologics
Frequently Asked Questions about the Global Market for Virus Filtration Products

What is the estimated value of the Global Market for Virus Filtration Products?

The Global Market for Virus Filtration Products was estimated to be valued at $3.1 Billion in 2020.

What is the growth rate of the Global Market for Virus Filtration Products?

The growth rate of the Global Market for Virus Filtration Products is 13.4%, with an estimated value of $6.6 Billion by 2026.

What is the forecasted size of the Global Market for Virus Filtration Products?

The Global Market for Virus Filtration Products is estimated to be worth $6.6 Billion by 2026.

Who are the key companies in the Global Market for Virus Filtration Products?

Key companies in the Global Market for Virus Filtration Products include Abbott Laboratories, Asahi Kasei Medical Co., Ltd., BioMérieux SA, Bio, Rad Laboratories, Inc., F. Hoffmann, La Roche AG, Hologic, Inc. and Pall Corporation.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • BioMérieux SA
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Lonza Group AG
  • Pall Corporation

I. METHODOLOGY


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Virus Filtration Products – Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • A Prelude to Virus Filtration
  • Virus Filtration in Biopharmaceuticals
  • Enhanced mAb Concentration
  • Impact of Covid-19 and a Looming Global Recession
  • 2020: A Year of Disruption & Transformation
  • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021
  • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • COVID-19 Impact on Virus Filtration Market
  • Global Market Prospects and Outlook
  • Virus Filtration Market Set for a Rapid Growth
  • Segment Analysis
  • Developed Regions Dominate, Developing to Witness Fastest Growth
  • Market Challenges
  • Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • An Expanding Biopharmaceuticals Sector Drives Growth Opportunities
  • Global Biopharmaceuticals Market: Revenues in US$ Billion for the Years 2019, 2021, 2023 and 2025
  • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
  • Pharmaceutical industry Opens Growth Avenues for Virus Filtration
  • Pharmaceutical R&D Spending Worldwide (USD Billion): 2015-2025
  • Advanced Virus Filters in the Pharmaceutical Industry
  • Filtration Technological Advancements Drive Market Growth
  • Filtration using Adsorption
  • Filtration Advancements
  • Mask Tracking and Tracing
  • Demographic Trends & Growing Incidence of Chronic Diseases to Push the Market Ahead
  • Global Population Statistics for the 60+ Age Group by Geographic Region: 2019
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • World Diabetes and Population Statistics (2019, 2030 & 2045)
  • Expansion of Single-Use Technologies in Virus Filtration Products
  • Virus Filtration for Biopharmaceutical Production
  • The Advent of Continuous Process Methods Drives Market Growth
  • Parvovirus Filtration Registers Steady Growth
  • Virus Retentive Filters Witness Rapid Growth
  • New Air Filters to Fight Against COVID-19
  • Manufacturers Show Virus Filtration Safety Techniques

4. GLOBAL MARKET PERSPECTIVE


III. MARKET ANALYSIS

UNITED STATES

  • Virus Filtration Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)

CANADA

JAPAN

  • Virus Filtration Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)

CHINA

  • Virus Filtration Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)

EUROPE

  • Virus Filtration Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)

FRANCE

  • Virus Filtration Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)

GERMANY

  • Virus Filtration Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)

ITALY

UNITED KINGDOM

  • Virus Filtration Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)

SPAIN


RUSSIA


REST OF EUROPE

ASIA-PACIFIC

  • Virus Filtration Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)

AUSTRALIA

  • Virus Filtration Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)

INDIA

  • Virus Filtration Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)

SOUTH KOREA


REST OF ASIA-PACIFIC

LATIN AMERICA

  • Virus Filtration Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)

ARGENTINA


BRAZIL


MEXICO


REST OF LATIN AMERICA

MIDDLE EAST

  • Virus Filtration Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)

AFRICA

  • Virus Filtration Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)

IV. COMPETITION

  • Total Companies Profiled: 41
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Asahi Kasei Medical Co., Ltd.
  • BioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Lonza Group AG
  • Pall Corporation
  • QIAGEN
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • WuXi Biologics
Note: Product cover images may vary from those shown